Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Actavis Buys Controlling Interest in China API Maker

publication date: Apr 10, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Actavis Group, a privately held generic pharmaceuticals company based in Iceland, has acquired a 90% stake in a China API maker, Zhejiang Chiral Medicine Chemicals Company. Actavis said that moving some of its API sourcing to Chiral would result in “significant” reduction in costs for the company. Terms of the transaction were not disclosed. Chiral, which was founded in 2001, employs almost 200 workers in its Hangzhou API manufacturing plant. Its products are sold to ex-China pharmaceutical companies. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners